Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesHigh-dose Daclizumab for the Treatment of Juvenile Idiopathic Arthritis-Associated Active Anterior Uveitis
American Journal of Ophthalmology, 08/07/09
Sen HN et al. – High–dose intravenous daclizumab can help reduce active inflammation in active JIA–associated anterior uveitis; however, patients need to be monitored for potential side effects. Larger randomized trials are needed to better assess treatment effect and safety.
Related Articles
Tubulointerstitial nephritis and uveitis syndrome
Current Opinion in Ophthalmology, 10/27/09
Relevance Score: 89%
Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/02/09
Relevance Score: 89%
Cataract Surgery Under Infliximab Therapy in a Patient With Behcet's Disease
Journal of Ocular Pharmacology and Therapeutics, 10/30/09
Relevance Score: 87%
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin
Eye, 10/26/09
Relevance Score: 87%
General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets, 10/09/09
Relevance Score: 87%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam
Pharmacoepidemiology and Drug Safety, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor